A refresher on colon healthGetting into the guts of what's normal, what's a red flag and which beverages are the most tolerable options when prepping for a colonoscopy. Tech presents CSHP webinar re Drug Access NavigatorsThe majority of DANs across Canada are pharmacy techs, especially given their understanding of drug billing. The five most common e-prescribing errors: ISMP Canada ISMP Canada found nearly 90 incidents linked to e-prescribing and community pharmacies over a five-year period. Type 2 diabetes is not one-size-fits-all: Subtypes affect complications and treatment options Although diabetes is broadly categorized into two main types, type 1 and type 2, each presents a diversity of subtypes, especially type 2 diabetes. ALS drug Albrioza to be voluntarily withdrawn from the market in Canada Phase 3 PHOENIX trial showed no significant benefit from Albrioza (sodium phenylbutyrate/ursodoxicoltaurine) compared to placebo. Safety of combining PDE5 inhibitors and nitrates Some studies have demonstrated lower mortality with phosphodiesterase-5 inhibitor treatment for erectile dysfunction in men with stable coronary artery disease, compared with no treatment. If you’ve tried meditating but can’t sit still, here’s how—and why—to try again When you inevitably get distracted—everyone does—notice the thought or urge to move, acknowledge it and bring your attention back to where you are. Escape plans to save your clinical day Here’s more advice to earlier career colleagues from Dr. Eric Cadesky. Understanding the interplay of menopausal hormone therapy and dementia For women under the age of 65 years, especially those under the age of 55 years, there appears to be no increased risk of dementia with MHT. ‘If you terminate me, I will ruin your life’ Here Dr. Jabir Jassam offers part one of a four-part series on: Why we burn out: The unseen hurdles. First Previous 108 109 110 111 112 Next Last
